Treatment of Non-Ulcer Dyspepsia
All patients with non-ulcer dyspepsia (functional dyspepsia) should first undergo H. pylori testing and receive eradication therapy if positive, followed by empirical proton pump inhibitor therapy if H. pylori-negative or symptoms persist, with tricyclic antidepressants reserved as second-line treatment. 1
Initial Diagnostic Approach
- Test all patients for H. pylori infection using non-invasive testing (urea breath test or stool antigen) and provide eradication therapy if positive, as this is the only treatment that may alter the natural history of the condition 1
- Perform full blood count in patients aged ≥55 years and coeliac serology in those with overlapping IBS-type symptoms 1
- Reserve urgent endoscopy only for patients aged ≥55 years with weight loss, or those aged >40 years from high gastric cancer risk areas or with family history of gastro-oesophageal cancer 1
First-Line Pharmacological Treatment
For H. pylori-Positive Patients
- Eradication therapy is highly efficacious (strong recommendation, high-quality evidence), though adverse events are more common than control therapy 1
- Confirm successful eradication only in patients at increased risk of gastric cancer 1
For H. pylori-Negative Patients or Persistent Symptoms
- Proton pump inhibitors (PPIs) are the first-line treatment (strong recommendation, high-quality evidence) 1
- Use the lowest effective dose that controls symptoms, as there is no dose-response relationship 1
- PPIs are well-tolerated and superior to H2-receptor antagonists, which have only weak evidence (weak recommendation, low-quality evidence) 1
Second-Line Treatment for Refractory Symptoms
Prokinetic Agents (for postprandial distress symptoms)
- Consider prokinetics only after H. pylori eradication and PPI trial have failed 2
- Acotiamide 100 mg three times daily is the preferred first-line prokinetic based on robust clinical trial data and long-term safety evidence 2
- Itopride is an alternative if acotiamide is unavailable or unaffordable 2
- Cintapride may be chosen for patients with overlapping GERD symptoms, but avoid combining with QT-prolonging agents 2
- Tegaserod has strong evidence (strong recommendation, moderate-quality evidence) but limited availability 1
- Note: Many prokinetics are unavailable outside Asia and the USA 1, 2
Tricyclic Antidepressants (TCAs)
- TCAs are efficacious second-line treatment (strong recommendation, moderate-quality evidence) when first-line therapies fail 1
- Start amitriptyline at 10 mg once daily at bedtime and titrate slowly to maximum 30-50 mg once daily 1
- Provide careful explanation that these are used as gut-brain neuromodulators, not for depression 1
- Counsel patients about side effect profile before initiating 1
Non-Pharmacological Management
- Advise all patients to take regular aerobic exercise (strong recommendation) 1
- Establish an empathic doctor-patient relationship with shared understanding of the condition, which may reduce healthcare utilization and improve quality of life 1
- Explain that functional dyspepsia is a disorder of gut-brain interaction with a chronic, fluctuating course affecting approximately two-thirds of patients long-term 3
- Discuss common symptom triggers and the gut-brain axis, including how diet, stress, and emotional responses impact symptoms 1
- There is insufficient evidence to recommend specific dietary therapies, including low-FODMAP diets 1
Referral Criteria
- Refer to gastroenterology when there is diagnostic doubt, severe symptoms, refractoriness to first-line treatments, or patient request for specialist opinion 1
- Ideally, manage referred patients in specialist clinics with access to dietetic support, efficacious drugs, and gut-brain behavioral therapies 1
Critical Pitfalls to Avoid
- Do not use prokinetics as first-line therapy—PPIs have stronger evidence and should be tried first 2
- Do not routinely perform gastric emptying testing or 24-hour pH monitoring in patients with typical functional dyspepsia symptoms 1
- Avoid opioids or surgery for refractory symptoms to minimize iatrogenic harm 3
- Counsel patients that prokinetics work best for meal-related symptoms (early satiety, postprandial fullness) rather than epigastric pain 2
- Involve dietitians early if food restriction develops to prevent overly restrictive diets 3